Investigational drug · Phase 2
TISA-818-Inj
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Acute Respiratory Distress Syndrome (ARDS).
Phase 2Last checked: Nov 20, 2026Latest source record: Jan 6, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
0 still active
All registered trials
2
Any phase or sponsor naming "TISA-818-Inj"
First trial start
2023
Oct 12, 2023
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "TISA-818-Inj", any sponsor or status.
Conditions studied
As listed on its trial records.
- Acute Respiratory Distress Syndrome (ARDS)
Approved drugs for the same conditions: Rare and genetic disease
Largest trials
Live from ClinicalTrials.gov: studies naming "TISA-818-Inj" as an intervention, largest first.
EnliTISA (Shanghai) Pharmaceutical Co., Ltd.Industry
NCT07319351 · 57 participants · Start Oct 12, 2023 · Primary completion Mar 25, 2025
Drug: TISA-818-Inj; TISA-818-Inj and 1 more · For: Acute Respiratory Distress Syndrome (ARDS)
Sites: Beijing, China
EnliTISA (Shanghai) Pharmaceutical Co., Ltd.Industry
NCT07337044 · 49 participants · Start Jan 24, 2024 · Primary completion Oct 16, 2024
Drug: TISA-818-Inj; Placebo · For: Healthy Subjects
Sites: Uppsala, Sweden
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Acute Respiratory Distress Syndrome (ARDS)
- CenthaquinePMZ-2010Phase 32 trials
Pharmazz, Inc. · Acute Respiratory Distress Syndrome (ARDS), Hypovolemic Shock
- STSA-1002Phase 32 trials
Staidson (Beijing) Biopharmaceuticals Co., Ltd · Acute Respiratory Distress Syndrome (ARDS), Acute Respiratory Distress Syndrome
- paridiprubartPhase 22 trials
PPD Development, LP · Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)
- vilobelimabPhase 22 trials
PPD Development, LP · Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)
- ALT-100Phase 21 trial
Aqualung Therapeutics Corp. · Acute Respiratory Distress Syndrome (ARDS)
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.